The following list announces FDA's tentatively scheduled advisory committee meetings for 2013. You may also obtain up-to-date information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area) or on the FDA Internet Web site under our 2013 tentative scheduled meeting listing athttp://www.fda.gov/AdvisoryCommittees/Calendar/ucm153468.htm.
Table 1 Committee name Tentative date(s) of meeting(s) OFFICE OF THE COMMISSIONER Pediatric Advisory Committee March 14-15, September 19-20.
Risk Communication Advisory Committee February 11-12, April 29-30, August 15-16, December 16-17.
Science Board to FDA February 27, June 24, November 20.
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH Allergenic Products Advisory Committee November 5-6.
Blood Products Advisory Committee February 12-13, April 8-9, August 1-2.
Cellular, Tissue and Gene Therapies January 15, April 17-18, June 27-28, Advisory Committee October 24-25.
Transmissible Spongiform March 14-15.
Encephalopathies Advisory Committee Vaccines and Related Biological February 27, May 8-9 or July 17-18 Products Advisory Committee (Backup date), September 18-19, November 13-14.
CENTER FOR DRUG EVALUATION AND RESEARCH Anesthetic and Analgesic Drug Products Date(s), if needed, to be determined.
Advisory Committee Anti-Infective Drugs Advisory Date(s), if needed, to be determined.
Committee Antiviral Drugs Advisory Committee May and October dates to be determined.
Arthritis Advisory Committee July or August and fall dates to be determined.
Cardiovascular and Renal Drugs April 17 and other date(s) to be Advisory Committee determined.
Dermatologic and Ophthalmic Drugs Date(s), if needed, to be determined.
Advisory Committee Drug Safety and Risk Management January 24-25, March 5.
Advisory Committee Endocrinologic and Metabolic Drugs January 10, July, and August dates to Advisory Committee be determined.
Gastrointestinal Drugs Advisory March 19 and other date(s) to be Committee determined.
Medical Imaging Drugs Advisory February 14 and May date to be Committee determined.
Nonprescription Drugs Advisory Date(s), if needed, to be determined.
Committee Oncologic Drugs Advisory April 5, May, June, July, September Committee date(s) to be determined.
Pharmacy Compounding Drugs Advisory Date(s), if needed, to be determined.
Committee Peripheral and Central Nervous System May 22.
Drugs Advisory Committee Advisory Committee for Pharmaceutical Date(s), if needed, to be determined.
Science and Clinical Pharmacology Psychopharmacologic Drugs Advisory Date(s), if needed, to be determined.
Committee Pulmonary-Allergy Drugs Advisory January 29-30, March 7.
Committee Advisory Committee for Reproductive March 4-5, July 9.
Health Drugs CENTER FOR DEVICES AND RADIOLOGICAL HEALTH Medical Devices Advisory Committee (Comprised of 18 Panels) Anesthesiology and Respiratory Therapy Date(s), if needed, to be determined.
Devices Panel Circulatory System Devices Panel May 17, May 24, June 27, September 27, November 22.
Clinical Chemistry and Clinical April 25.
Toxicology Devices Panel Dental Products Panel Date(s), if needed, to be determined.
Ear, Nose, and Throat Devices Panel July 12.
Gastroenterology-Urology Devices Panel April 24, May 16.
General and Plastic Surgery Devices June 13.
Panel General Hospital and Personal Use June 28, August 30.
Devices Panel Hematology and Pathology Devices Panel Date(s), if needed, to be determined.
Immunology Devices Panel Date(s), if needed, to be determined.
Medical Devices Dispute Resolution Date(s), if needed, to be determined.
Panel Microbiology Devices Panel June 14.
Molecular and Clinical Genetics Panel September 13.
Neurological Devices Panel February 22.
Obstetrics and Gynecology Devices September 20.
Panel Ophthalmic Devices Panel June 14, August 23.
Orthopaedic and Rehabilitation Devices April 5, September 26.
Panel Radiological Devices Panel September 12.
Device Good Manufacturing Practice April 11.
Advisory Committee National Mammography Quality Assurance October 25.
Advisory Committee Technical Electronic Product Radiation Date(s), if needed, to be determined.
Safety Standards Committee CENTER FOR FOOD SAFETY AND APPLIED NUTRITION Food Advisory Committee July 15-16, August 29-30, September 23-24.
CENTER FOR TOBACCO PRODUCTS Tobacco Products Scientific Advisory Feb 11-12, April 30-May 1.
Committee CENTER FOR VETERINARY MEDICINE Veterinary Medicine Advisory Committee Date(s), if needed, to be determined.
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR) Science Advisory Board to NCTR December 10-11.
Dated: December 26, 2012.
Leslie Kux, Assistant Commissioner for Policy.
[FR Doc. 2012-31475 Filed 12-31-12; 8:45 am] BILLING CODE 4160-01-P Vol. 78, No. 001 [Docket No. FDA-2012-N-0001] Notices
Table 1 Committee name Tentative date(s) of meeting(s) OFFICE OF THE COMMISSIONER Pediatric Advisory Committee March 14-15, September 19-20.
Risk Communication Advisory Committee February 11-12, April 29-30, August 15-16, December 16-17.
Science Board to FDA February 27, June 24, November 20.
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH Allergenic Products Advisory Committee November 5-6.
Blood Products Advisory Committee February 12-13, April 8-9, August 1-2.
Cellular, Tissue and Gene Therapies January 15, April 17-18, June 27-28, Advisory Committee October 24-25.
Transmissible Spongiform March 14-15.
Encephalopathies Advisory Committee Vaccines and Related Biological February 27, May 8-9 or July 17-18 Products Advisory Committee (Backup date), September 18-19, November 13-14.
CENTER FOR DRUG EVALUATION AND RESEARCH Anesthetic and Analgesic Drug Products Date(s), if needed, to be determined.
Advisory Committee Anti-Infective Drugs Advisory Date(s), if needed, to be determined.
Committee Antiviral Drugs Advisory Committee May and October dates to be determined.
Arthritis Advisory Committee July or August and fall dates to be determined.
Cardiovascular and Renal Drugs April 17 and other date(s) to be Advisory Committee determined.
Dermatologic and Ophthalmic Drugs Date(s), if needed, to be determined.
Advisory Committee Drug Safety and Risk Management January 24-25, March 5.
Advisory Committee Endocrinologic and Metabolic Drugs January 10, July, and August dates to Advisory Committee be determined.
Gastrointestinal Drugs Advisory March 19 and other date(s) to be Committee determined.
Medical Imaging Drugs Advisory February 14 and May date to be Committee determined.
Nonprescription Drugs Advisory Date(s), if needed, to be determined.
Committee Oncologic Drugs Advisory April 5, May, June, July, September Committee date(s) to be determined.
Pharmacy Compounding Drugs Advisory Date(s), if needed, to be determined.
Committee Peripheral and Central Nervous System May 22.
Drugs Advisory Committee Advisory Committee for Pharmaceutical Date(s), if needed, to be determined.
Science and Clinical Pharmacology Psychopharmacologic Drugs Advisory Date(s), if needed, to be determined.
Committee Pulmonary-Allergy Drugs Advisory January 29-30, March 7.
Committee Advisory Committee for Reproductive March 4-5, July 9.
Health Drugs CENTER FOR DEVICES AND RADIOLOGICAL HEALTH Medical Devices Advisory Committee (Comprised of 18 Panels) Anesthesiology and Respiratory Therapy Date(s), if needed, to be determined.
Devices Panel Circulatory System Devices Panel May 17, May 24, June 27, September 27, November 22.
Clinical Chemistry and Clinical April 25.
Toxicology Devices Panel Dental Products Panel Date(s), if needed, to be determined.
Ear, Nose, and Throat Devices Panel July 12.
Gastroenterology-Urology Devices Panel April 24, May 16.
General and Plastic Surgery Devices June 13.
Panel General Hospital and Personal Use June 28, August 30.
Devices Panel Hematology and Pathology Devices Panel Date(s), if needed, to be determined.
Immunology Devices Panel Date(s), if needed, to be determined.
Medical Devices Dispute Resolution Date(s), if needed, to be determined.
Panel Microbiology Devices Panel June 14.
Molecular and Clinical Genetics Panel September 13.
Neurological Devices Panel February 22.
Obstetrics and Gynecology Devices September 20.
Panel Ophthalmic Devices Panel June 14, August 23.
Orthopaedic and Rehabilitation Devices April 5, September 26.
Panel Radiological Devices Panel September 12.
Device Good Manufacturing Practice April 11.
Advisory Committee National Mammography Quality Assurance October 25.
Advisory Committee Technical Electronic Product Radiation Date(s), if needed, to be determined.
Safety Standards Committee CENTER FOR FOOD SAFETY AND APPLIED NUTRITION Food Advisory Committee July 15-16, August 29-30, September 23-24.
CENTER FOR TOBACCO PRODUCTS Tobacco Products Scientific Advisory Feb 11-12, April 30-May 1.
Committee CENTER FOR VETERINARY MEDICINE Veterinary Medicine Advisory Committee Date(s), if needed, to be determined.
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR) Science Advisory Board to NCTR December 10-11.
Dated: December 26, 2012.
Leslie Kux, Assistant Commissioner for Policy.
[FR Doc. 2012-31475 Filed 12-31-12; 8:45 am] BILLING CODE 4160-01-P Vol. 78, No. 001 [Docket No. FDA-2012-N-0001] Notices